Dow Down 0.02% Nasdaq Up 0.07%

Sinovac Biotech Ltd. (SVA)

-NasdaqGS
5.04 0.04(0.79%) Nov 25, 4:00PM EST
Prev Close:5.08
Open:5.06
Bid:4.65 x 1500
Ask:N/A
1y Target Est:9.50
Beta:0.08
Next Earnings Date:N/A
Day's Range:4.92 - 5.06
52wk Range:4.51 - 8.14
Volume:52,794
Avg Vol (3m):179,342
Market Cap:280.84M
P/E (ttm):84.00
EPS (ttm):0.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SVADown 0.79%280.84M
GSK111.26B
SNY125.04B

Key Statistics

Forward P/E (1 yr):56.00
P/S (ttm):4.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.06
Quarterly EPS Est (Dec-14) :0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-7.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback